198 related articles for article (PubMed ID: 35730025)
1. QSAR, homology modeling, and docking simulation on SARS-CoV-2 and pseudomonas aeruginosa inhibitors, ADMET, and molecular dynamic simulations to find a possible oral lead candidate.
Edache EI; Uzairu A; Mamza PA; Shallangwa GA
J Genet Eng Biotechnol; 2022 Dec; 20():88. PubMed ID: 35730025
[TBL] [Abstract][Full Text] [Related]
2. QSAR based virtual screening derived identification of a novel hit as a SARS CoV-229E 3CL
Jawarkar RD; Bakal RL; Zaki MEA; Al-Hussain S; Ghosh A; Gandhi A; Mukerjee N; Samad A; Masand VH; Lewaa I
Arab J Chem; 2022 Jan; 15(1):103499. PubMed ID: 34909066
[TBL] [Abstract][Full Text] [Related]
3. Identification of Anti-SARS-CoV-2 Compounds from Food Using QSAR-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation Analysis.
Zaki MEA; Al-Hussain SA; Masand VH; Akasapu S; Bajaj SO; El-Sayed NNE; Ghosh A; Lewaa I
Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33924395
[TBL] [Abstract][Full Text] [Related]
4. Molecular dynamics simulation, 3D-pharmacophore and scaffold hopping analysis in the design of multi-target drugs to inhibit potential targets of COVID-19.
Fayyazi N; Mostashari-Rad T; Ghasemi JB; Ardakani MM; Kobarfard F
J Biomol Struct Dyn; 2022; 40(22):11787-11808. PubMed ID: 34405765
[TBL] [Abstract][Full Text] [Related]
5. Computational modelling studies of some 1,3-thiazine derivatives as anti-influenza inhibitors targeting H1N1 neuraminidase via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions.
Abdullahi M; Uzairu A; Shallangwa GA; Mamza PA; Ibrahim MT
Beni Suef Univ J Basic Appl Sci; 2022; 11(1):104. PubMed ID: 36000144
[TBL] [Abstract][Full Text] [Related]
6. Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations.
Oubahmane M; Hdoufane I; Delaite C; Sayede A; Cherqaoui D; El Allali A
Pharmaceuticals (Basel); 2023 Apr; 16(4):. PubMed ID: 37111365
[TBL] [Abstract][Full Text] [Related]
7. Quantitative structure-activity relationships, molecular docking and molecular dynamics simulations reveal drug repurposing candidates as potent SARS-CoV-2 main protease inhibitors.
de Souza AS; de Souza RF; Guzzo CR
J Biomol Struct Dyn; 2022; 40(21):11339-11356. PubMed ID: 34370631
[TBL] [Abstract][Full Text] [Related]
8.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
9. Some Flavolignans as Potent Sars-Cov-2 Inhibitors
Cetin A
Curr Comput Aided Drug Des; 2022; 18(5):337-346. PubMed ID: 35975852
[TBL] [Abstract][Full Text] [Related]
10. Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches.
Bakal RL; Jawarkar RD; Manwar JV; Jaiswal MS; Ghosh A; Gandhi A; Zaki MEA; Al-Hussain S; Samad A; Masand VH; Mukerjee N; Nasir Abbas Bukhari S; Sharma P; Lewaa I
Saudi Pharm J; 2022 Jun; 30(6):693-710. PubMed ID: 35812153
[TBL] [Abstract][Full Text] [Related]
11. The anti-SARS-CoV-2 activity of novel 9, 10-dihydrophenanthrene derivatives: an insight into molecular docking, ADMET analysis, and molecular dynamics simulation.
Yamari I; Abchir O; Mali SN; Errougui A; Talbi M; Kouali ME; Chtita S
Sci Afr; 2023 Sep; 21():e01754. PubMed ID: 37332393
[TBL] [Abstract][Full Text] [Related]
12. Potential SARS-CoV-2 RdRp inhibitors of cytidine derivatives: Molecular docking, molecular dynamic simulations, ADMET, and POM analyses for the identification of pharmacophore sites.
M A Kawsar S; Hosen MA; Ahmad S; El Bakri Y; Laaroussi H; Ben Hadda T; Almalki FA; Ozeki Y; Goumri-Said S
PLoS One; 2022; 17(11):e0273256. PubMed ID: 36441684
[TBL] [Abstract][Full Text] [Related]
13. In-silico studies of 2-aminothiazole derivatives as anticancer agents by QSAR, molecular docking, MD simulation and MM-GBSA approaches.
Chitre TS; Hirode PV; Lokwani DK; Bhatambrekar AL; Hajare SG; Thorat SB; Priya D; Pradhan KB; Asgaonkar KD; Jain SP
J Biomol Struct Dyn; 2023 Oct; ():1-19. PubMed ID: 37811574
[TBL] [Abstract][Full Text] [Related]
14. In search of RdRp and Mpro inhibitors against SARS CoV-2: Molecular docking, molecular dynamic simulations and ADMET analysis.
Gajjar ND; Dhameliya TM; Shah GB
J Mol Struct; 2021 Sep; 1239():130488. PubMed ID: 33903778
[TBL] [Abstract][Full Text] [Related]
15. Virtual screening of PEBP1 inhibitors by combining 2D/3D-QSAR analysis, hologram QSAR, homology modeling, molecular docking analysis, and molecular dynamic simulations.
Stitou M; Toufik H; Akabli T; Lamchouri F
J Mol Model; 2022 May; 28(6):145. PubMed ID: 35545728
[TBL] [Abstract][Full Text] [Related]
16. Rational identification of small molecules derived from 9,10-dihydrophenanthrene as potential inhibitors of 3CL
Daoui O; Elkhattabi S; Chtita S
Struct Chem; 2022; 33(5):1667-1690. PubMed ID: 35818588
[TBL] [Abstract][Full Text] [Related]
17. COVID-19: In silico identification of potent α-ketoamide inhibitors targeting the main protease of the SARS-CoV-2.
Oubahmane M; Hdoufane I; Bjij I; Jerves C; Villemin D; Cherqaoui D
J Mol Struct; 2021 Nov; 1244():130897. PubMed ID: 34149065
[TBL] [Abstract][Full Text] [Related]
18. In silico molecular investigations of pyridine N-Oxide compounds as potential inhibitors of SARS-CoV-2: 3D QSAR, molecular docking modeling, and ADMET screening.
Ghaleb A; Aouidate A; Ayouchia HBE; Aarjane M; Anane H; Stiriba SE
J Biomol Struct Dyn; 2022 Jan; 40(1):143-153. PubMed ID: 32799761
[TBL] [Abstract][Full Text] [Related]
19. Phytoconstituents from ten natural herbs as potent inhibitors of main protease enzyme of SARS-COV-2:
Kumar N; Singh A; Gulati HK; Bhagat K; Kaur K; Kaur J; Dudhal S; Duggal A; Gulati P; Singh H; Singh JV; Bedi PMS
Phytomed Plus; 2021 Nov; 1(4):100083. PubMed ID: 35403086
[TBL] [Abstract][Full Text] [Related]
20. Plant derived active compounds as potential anti SARS-CoV-2 agents: an
Kashyap D; Jakhmola S; Tiwari D; Kumar R; Moorthy NSHN; Elangovan M; Brás NF; Jha HC
J Biomol Struct Dyn; 2022; 40(21):10629-10650. PubMed ID: 34225565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
